PDF herunterladen
Thromb Haemost 2022; 122(02): 267-276
DOI: 10.1055/a-1497-9777
Stroke, Systemic or Venous Thromboembolism

Joint Effect of Multiple Prothrombotic Genotypes and Obesity on the Risk of Incident Venous Thromboembolism

Tobias Frischmuth 
1   Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), UiT - The Arctic University of Norway, Tromsø, Norway
,
Kristian Hindberg
1   Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), UiT - The Arctic University of Norway, Tromsø, Norway
,
Maiken E. Gabrielsen
2   Department of Public Health, K. G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway
,
Ben Brumpton
2   Department of Public Health, K. G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway
,
Kristian Hveem
2   Department of Public Health, K. G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway
3   Department of Public Health, HUNT Research Center, Norwegian University of Science and Technology, Levanger, Norway
,
Sigrid K. Brækkan
1   Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), UiT - The Arctic University of Norway, Tromsø, Norway
4   Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
,
John-Bjarne Hansen
1   Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), UiT - The Arctic University of Norway, Tromsø, Norway
4   Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
,
Vânia M. Morelli
1   Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), UiT - The Arctic University of Norway, Tromsø, Norway
› Institutsangaben Funding K.G. Jebsen TREC and K.G. Jebsen Center for Genetic Epidemiology are supported by independent grants from Stiftelsen Kristian Gerhard Jebsen. The Trøndelag Health Study (The HUNT Study) is a collaboration between HUNT Research Centre (Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology), Trøndelag County Council, Central Norway Regional Health Authority, and the Norwegian Institute of Public Health. The genotyping in HUNT was financed by the National Institutes of Health; University of Michigan; the Research Council of Norway; the Liaison Committee for Education, Research and Innovation in Central Norway; and the Joint Research Committee between St Olav's Hospital and the Faculty of Medicine and Health Sciences, NTNU. T. Frischmuth is supported by the Northern Norway Regional Health Authority.
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Background The impact of the combination of obesity and multiple prothrombotic genotypes on venous thromboembolism (VTE) risk remains unclear.

Objective To investigate the joint effect of obesity and a genetic risk score (GRS) composed of established prothrombotic single nucleotide polymorphisms (SNPs) on VTE risk using a population-based case–cohort.

Methods Cases with incident VTE (n = 1,470) and a subcohort (n = 12,826) were derived from the Tromsø Study (1994–2012) and the Trøndelag Health Study (HUNT) (1995–2008). Participants were genotyped for ABO (rs8176719), F5 (rs6025), F2 (rs1799963), FGG (rs2066865), and F11 (rs2036914) SNPs. Age- and sex-adjusted hazard ratios (HRs) were estimated according to body mass index (BMI) categories and number of risk alleles for individual SNPs and the GRS (0–1, 2, 3, ≥4 alleles).

Results The combination of obesity (BMI ≥ 30kg/m2) and risk alleles, either as individual SNPs or as a GRS, had an additive effect on VTE risk (i.e., no biological interaction). Obese subjects who were carriers of ≥4 risk alleles had a 2.85-fold (95% confidence interval [CI]: 2.05–3.96) increased risk of overall VTE compared with those with BMI <25 kg/m2 and 0 to 1 risk allele. However, in subgroups, the combination of obesity and ≥4 risk alleles was more pronounced for deep vein thrombosis (DVT) (HR: 3.20; 95% CI: 2.09–4.90) and unprovoked VTE (HR: 3.82; 95% CI: 2.25–6.47), suggesting a supra-additive effect.

Conclusion Our findings indicate that the combination of obesity and GRS has an additive effect on the risk of overall VTE. However, it may have a supra-additive effect on the risk of DVT and unprovoked VTE.

Keywords

deep vein thrombosis - interaction - obesity - single nucleotide polymorphisms - venous thromboembolism

Author Contributions

T.F. analyzed data, interpreted the results, and drafted the manuscript. K.H. provided statistical support, interpreted the results, and revised the manuscript. M.E.G., B.B., and K.H. organized data collection and revised the manuscript. S.K.B. designed the study, organized data collection, interpreted the results, contributed to the manuscript draft, and revised the manuscript. J-.B. H. designed the study, organized data collection, interpreted the results, and revised the manuscript. V.M.M. designed the study, interpreted the results, contributed to the manuscript draft, and revised the manuscript. All authors reviewed and approved the final version of the manuscript.


Supplementary Material



Publikationsverlauf

Eingereicht: 12. Januar 2021

Angenommen: 30. April 2021

Accepted Manuscript online:
03. Mai 2021

Artikel online veröffentlicht:
25. Juni 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5 (04) 692-699
    CrossrefPubMedGoogle Scholar
  • 2 Arshad N, Isaksen T, Hansen JB, Brækkan SK. Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population. Eur J Epidemiol 2017; 32 (04) 299-305
    CrossrefPubMedGoogle Scholar
  • 3 World Health Organization (WHO). Fact sheet: obesity and overweight. 2018 . Accessed February 24, 2020 at: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight
    PubMedGoogle Scholar
  • 4 Braekkan SK, Siegerink B, Lijfering WM, Hansen JB, Cannegieter SC, Rosendaal FR. Role of obesity in the etiology of deep vein thrombosis and pulmonary embolism: current epidemiological insights. Semin Thromb Hemost 2013; 39 (05) 533-540
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 5 Rahmani J, Haghighian Roudsari A, Bawadi H. et al. Relationship between body mass index, risk of venous thromboembolism and pulmonary embolism: a systematic review and dose-response meta-analysis of cohort studies among four million participants. Thromb Res 2020; 192: 64-72
    CrossrefPubMedGoogle Scholar
  • 6 Horvei LD, Brækkan SK, Hansen JB. Weight change and risk of venous thromboembolism: the Tromsø Study. PLoS One 2016; 11 (12) e0168878
    CrossrefPubMedGoogle Scholar
  • 7 Heit JA, Ashrani A, Crusan DJ, McBane RD, Petterson TM, Bailey KR. Reasons for the persistent incidence of venous thromboembolism. Thromb Haemost 2017; 117 (02) 390-400
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 8 Klovaite J, Benn M, Nordestgaard BG. Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study. J Intern Med 2015; 277 (05) 573-584
    CrossrefPubMedGoogle Scholar
  • 9 Klarin D, Emdin CA, Natarajan P, Conrad MF, Kathiresan S. INVENT Consortium. Genetic analysis of venous thromboembolism in UK Biobank identifies the ZFPM2 locus and implicates obesity as a causal risk factor. Circ Cardiovasc Genet 2017; 10 (02) e001643
    CrossrefPubMedGoogle Scholar
  • 10 Lindström S, Germain M, Crous-Bou M. et al; INVENT Consortium. Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian randomization study. Hum Genet 2017; 136 (07) 897-902
    CrossrefPubMedGoogle Scholar
  • 11 Larsson SC, Bäck M, Rees JMB, Mason AM, Burgess S. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. Eur Heart J 2020; 41 (02) 221-226
    CrossrefPubMedGoogle Scholar
  • 12 de Haan HG, Bezemer ID, Doggen CJ. et al. Multiple SNP testing improves risk prediction of first venous thrombosis. Blood 2012; 120 (03) 656-663
    CrossrefPubMedGoogle Scholar
  • 13 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353 (9159): 1167-1173
    CrossrefPubMedGoogle Scholar
  • 14 Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 2007; 139 (02) 289-296
    CrossrefPubMedGoogle Scholar
  • 15 Severinsen MT, Overvad K, Johnsen SP. et al. Genetic susceptibility, smoking, obesity and risk of venous thromboembolism. Br J Haematol 2010; 149 (02) 273-279
    CrossrefPubMedGoogle Scholar
  • 16 Christiansen SC, Lijfering WM, Naess IA. et al. The relationship between body mass index, activated protein C resistance and risk of venous thrombosis. J Thromb Haemost 2012; 10 (09) 1761-1767
    CrossrefPubMedGoogle Scholar
  • 17 Ribeiro DD, Lijfering WM, Rosendaal FR, Cannegieter SC. Risk of venous thrombosis in persons with increased body mass index and interactions with other genetic and acquired risk factors. J Thromb Haemost 2016; 14 (08) 1572-1578
    CrossrefPubMedGoogle Scholar
  • 18 Kim J, Kraft P, Hagan KA, Harrington LB, Lindstroem S, Kabrhel C. Interaction of a genetic risk score with physical activity, physical inactivity, and body mass index in relation to venous thromboembolism risk. Genet Epidemiol 2018; 42 (04) 354-365
    CrossrefPubMedGoogle Scholar
  • 19 van Langevelde K, Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Cannegieter SC. Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood 2012; 120 (05) 933-946
    CrossrefPubMedGoogle Scholar
  • 20 Weingarz L, Schwonberg J, Schindewolf M. et al. Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry. Br J Haematol 2013; 163 (05) 655-665
    CrossrefPubMedGoogle Scholar
  • 21 Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: the Tromso Study. Int J Epidemiol 2012; 41 (04) 961-967
    CrossrefPubMedGoogle Scholar
  • 22 Holmen J, Midthjell K, Krüger Ø. et al. The Nord-Trøndelag Health Study 1995–97 (HUNT2). Nor Epidemiol 2011; 13 (01) 19-32
    PubMedGoogle Scholar
  • 23 Braekkan SK, Borch KH, Mathiesen EB, Njølstad I, Wilsgaard T, Hansen JB. Body height and risk of venous thromboembolism: the Tromsø Study. Am J Epidemiol 2010; 171 (10) 1109-1115
    CrossrefPubMedGoogle Scholar
  • 24 Småbrekke B, Rinde LB, Evensen LH. et al. Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism. J Thromb Haemost 2019; 17 (08) 1363-1371
    CrossrefPubMedGoogle Scholar
  • 25 Horvei LD, Braekkan SK, Smith EN. et al. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø Study. J Thromb Haemost 2018; 16 (01) 83-89
    CrossrefPubMedGoogle Scholar
  • 26 Li Y, Bezemer ID, Rowland CM. et al. Genetic variants associated with deep vein thrombosis: the F11 locus. J Thromb Haemost 2009; 7 (11) 1802-1808
    CrossrefPubMedGoogle Scholar
  • 27 Rothman KJ. Measuring interactions. In: Epidemiology: An Introduction. New York, NY: Oxford University Press; 2002: 168-180
    Google Scholar
  • 28 Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005; 20 (07) 575-579
    CrossrefPubMedGoogle Scholar
  • 29 Vandenbroucke JP, von Elm E, Altman DG. et al; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 2007; 18 (06) 805-835
    CrossrefPubMedGoogle Scholar
  • 30 Crous-Bou M, De Vivo I, Camargo Jr CA. et al. Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism. Thromb Haemost 2016; 116 (04) 705-713
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 31 Shaya SA, Westrick RJ, Gross PL. Thrombus stability explains the factor V Leiden paradox: a mouse model. Blood Adv 2019; 3 (21) 3375-3378
    CrossrefPubMedGoogle Scholar
  • 32 Bertina RM, Koeleman BP, Koster T. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369 (6475): 64-67
    CrossrefPubMedGoogle Scholar
  • 33 Lowe GD, Rumley A, Woodward M, Reid E, Rumley J. Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variables. Thromb Haemost 1999; 81 (06) 918-924
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 34 Morelli VM, de Visser MC, van Tilburg NH. et al. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens. Thromb Haemost 2007; 97 (04) 534-541
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 35 Kaye SM, Pietiläinen KH, Kotronen A. et al. Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs. Obesity (Silver Spring) 2012; 20 (01) 88-94
    CrossrefPubMedGoogle Scholar
  • 36 Clarke R, Shipley M, Lewington S. et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999; 150 (04) 341-353
    CrossrefPubMedGoogle Scholar
  • 37 Småbrekke B, Rinde LB, Hindberg K. et al. Atherosclerotic risk factors and risk of myocardial infarction and venous thromboembolism; time-fixed versus time-varying analyses. the Tromsø Study. PLoS One 2016; 11 (09) e0163242
    CrossrefPubMedGoogle Scholar